Metraipolis › archive › dc_ee083e72c9ee

An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease — Europe PMC PMID:40871562

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40871562
DOI
10.3390/molecules30163409
License (as archived)
solo-consultazione
Archived
2026-11-10T13:36:54.720Z
SHA-256 of the archived text
698f8efe6540f95ae321c027bce22cf15d638f409db45a138ac3de178632d41a
Stable URL of this page
https://metraipolis.com/documento/dc_ee083e72c9ee

How to cite

An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease — Europe PMC PMID:40871562 — Europe PMC (en), https://europepmc.org/article/MED/40871562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee083e72c9ee (Metraipolis archive dc_ee083e72c9ee, sha256 698f8efe6540f95ae321c027bce22cf15d638f409db45a138ac3de178632d41a)
BibTeX
@misc{dcee083e72c9ee,
  title = {An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease — Europe PMC PMID:40871562},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40871562},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee083e72c9ee; sha256 698f8efe6540f95ae321c027bce22cf15d638f409db45a138ac3de178632d41a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40871562. Agents can read the archived copy with the MCP tool read_document.